Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Herskovitz

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.
Plos One|August 6, 2016
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based BiotherapeuticsMarisa K Joubert, Meghana Deshpande, Jane Yang, et al.
Biomaterials|December 23, 2019
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle trackingInsiya Z Mukadam, Jatin Machhi, Jonathan Herskovitz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 23, 2020
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 InfectionsJatin Machhi, Jonathan Herskovitz, Ahmed M Senan, et al.
FEMS Microbiology Reviews|June 23, 2021
The Immunopathobiology of SARS-CoV-2 InfectionMilankumar Patel, Farah Shahjin, Jacob D Cohen, et al.
Theranostics|January 7, 2020
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissuesBhavesh D Kevadiya, Brendan Ottemann, Insiya Z Mukadam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2019
Creation of a long-acting rilpivirine prodrug nanoformulationJames R Hilaire, Aditya N Bade, Brady Sillman, et al.
Journal of Neuroinflammation|November 20, 2021
CD4+ effector T cells accelerate Alzheimer's disease in miceJatin Machhi, Pravin Yeapuri, Yaman Lu, et al.
Nature Materials|February 16, 2021
Diagnostics for SARS-CoV-2 infectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Plos Pathogens|January 26, 2016
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistenceCameron R Cunningham, Ameya Champhekar, Michael V Tullius, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.
Plos One|August 6, 2016
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based BiotherapeuticsMarisa K Joubert, Meghana Deshpande, Jane Yang, et al.
Biomaterials|December 23, 2019
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle trackingInsiya Z Mukadam, Jatin Machhi, Jonathan Herskovitz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 23, 2020
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 InfectionsJatin Machhi, Jonathan Herskovitz, Ahmed M Senan, et al.
FEMS Microbiology Reviews|June 23, 2021
The Immunopathobiology of SARS-CoV-2 InfectionMilankumar Patel, Farah Shahjin, Jacob D Cohen, et al.
Theranostics|January 7, 2020
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissuesBhavesh D Kevadiya, Brendan Ottemann, Insiya Z Mukadam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2019
Creation of a long-acting rilpivirine prodrug nanoformulationJames R Hilaire, Aditya N Bade, Brady Sillman, et al.
Journal of Neuroinflammation|November 20, 2021
CD4+ effector T cells accelerate Alzheimer's disease in miceJatin Machhi, Pravin Yeapuri, Yaman Lu, et al.
Nature Materials|February 16, 2021
Diagnostics for SARS-CoV-2 infectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Plos Pathogens|January 26, 2016
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistenceCameron R Cunningham, Ameya Champhekar, Michael V Tullius, et al.
Pageof 3